DAWNRAYS PHARMA 02348·

Gross margin 58.47%--60.54%2.07%55.73%4.81%54.48%1.25%49.73%4.74% Net margin 30.40%--27.85%2.54%28.03%0.18%53.08%25.05%17.15%35.92% ROE 15.04%--13.55%1.49%11.42%2.13%16.99%5.57%6.32%10.67% ROA 10.61%--9.69%0.92%8.91%0.78%14.04%5.13%5.27%8.77% Revenue growth ----9.66%---9.90%19.56%-7.89%2.01%16.09%23.98% Attributable profit growth -----0.03%---8.95%8.92%73.29%82.25%-62.13%135.42% Debt-to-assets 28.20%--27.85%0.35%21.07%6.77%17.03%4.05%15.57%1.45% Current ratio 2.17--1.870.302.570.703.971.404.640.67 Operating cash flow / net profit 1.11--1.220.111.050.170.390.661.681.29 Operating cash flow / revenue 33.74%--33.99%0.25%29.40%4.59%20.77%8.63%28.87%8.11%

Gross margin 49.80%--51.80%2.00% Net margin 16.13%--22.60%6.46% Revenue growth -----13.42%-- Attributable profit growth ----17.95%-- Debt-to-assets ----13.93%-- Current ratio ----5.38-- Operating cash flow / net profit 1.99--1.540.44 Operating cash flow / revenue 32.04%--34.86%2.82%

Revenue 1.17B--1.28B9.66%1.15B9.90%1.06B7.89%1.23B16.09% Other income and gains 135.88M--86.95M36.01%185.77M113.66%451.96M143.29%59.53M86.83% Gross profit 681.26M--773.55M13.55%641.52M17.07%577.63M9.96%612.15M5.98% Selling and distribution expenses 109.03M--142.73M30.91%147.05M3.02%127.83M13.07%106.00M17.08% Administrative expenses 117.41M--122.06M3.96%113.21M7.25%130.37M15.16%138.28M6.07% Net finance costs 641.00K--371.00K42.12%989.00K166.58%3.61M264.81%496.00K86.25% Income tax 85.16M--82.56M3.06%91.39M10.70%74.19M18.82%38.51M48.10% Operating profit 486.38M--500.68M2.94%455.98M8.93%644.25M41.29%250.11M61.18% Share of associates and JVs -46.42M---61.91M33.36%-40.93M33.88%-3.70M90.97%---- Profit before tax 439.32M--438.41M0.21%414.06M5.55%636.95M53.83%249.61M60.81% Net profit 354.16M--355.85M0.48%322.67M9.33%562.76M74.41%211.11M62.49% Net profit attributable to owners 358.18M--358.06M0.03%326.00M8.95%564.94M73.29%213.97M62.13%

Revenue 630.42M--545.84M13.42% Other income and gains 30.86M--43.02M39.42% Cost of sales 316.45M--263.09M16.86% Gross profit 313.98M--282.75M9.95% Selling and distribution expenses 56.83M--39.40M30.68% Administrative expenses 67.49M--62.11M7.97% Net finance costs 314.00K--583.00K85.67% Income tax 28.61M--34.81M21.69% Profit before tax 130.32M--158.16M21.36% Net profit 101.71M--123.34M21.27% Net profit attributable to owners 104.57M--123.34M17.95%

Cash and cash equivalents 577.74M--811.68M40.49%905.83M11.60%1.16B27.87%1.17B0.71% Trade and bills receivables 346.78M--402.85M16.17%322.00M20.07%267.89M16.80%265.22M0.99% Inventories 203.48M--241.75M18.81%211.11M12.67%308.24M46.01%215.44M30.11% Total current assets 1.51B--1.74B15.42%1.72B1.36%2.20B28.02%2.29B4.15% Total assets 3.34B--3.67B9.97%3.62B1.36%4.01B10.67%4.01B0.00% Total current liabilities 697.10M--932.06M33.70%668.94M28.23%554.60M17.09%493.97M10.93% Total liabilities 941.70M--1.02B8.61%763.42M25.36%682.61M10.59%624.36M8.53% Equity attributable to owners 2.38B--2.64B10.97%2.85B8.05%3.32B16.45%3.39B1.83% Total equity 2.40B--2.65B10.51%2.86B7.90%3.33B16.35%3.39B1.75%

Cash and cash equivalents ----1.29B-- Trade and bills receivables ----252.31M-- Inventories ----209.03M-- Total current assets ----2.29B-- Total assets ----3.99B-- Total current liabilities ----425.25M-- Total liabilities ----555.71M-- Equity attributable to owners ----3.43B-- Total equity ----3.43B--

Net cash from operating activities 393.14M--434.27M10.46%338.40M22.08%220.20M34.93%355.41M61.40% Net cash from investing activities -284.20M---175.01M38.42%-387.57M121.45%205.17M152.94%-368.80M279.75% Net cash from financing activities -129.75M---92.70M28.56%2.07M102.23%-189.44M9251.59%-54.99M70.97% Net change in cash -20.82M--166.55M900.08%-47.10M128.28%235.93M600.89%-68.38M128.98%

Net cash from operating activities 201.98M--190.27M5.80% Net cash from investing activities -439.07M---265.18M39.60% Net cash from financing activities -127.40M---133.59M4.86% Net change in cash -364.49M---208.50M42.80%